Isomorphic signs up Lilly, Novartis for $3bn AI drug hunt
pharmaphorum
JANUARY 8, 2024
Alphabet’s AI in drug discovery startup Isomorphic Labs signs collaborations with Eli Lilly and Novartis worth up to $3bn, its first two pharma partnerships
sign-up 
Genentech signs nanoparticle deal worth up to $644m with GenEdit
Pharmaceutical Technology
JANUARY 23, 2024
Genentech will utilise GenEdit’s non-viral polymer nanoparticles for gene therapy delivery in autoimmune diseases.
Gene Therapy 
240
240 Join 32,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Owkin signs up another pharma partner for its AI platform
pharmaphorum
OCTOBER 17, 2023
Owkin signs up another pharma partner for its AI platform Phil.Taylor Tue, 17/10/2023 - 10:29 Bookmark this
100 
ImmunoGen signs loan agreement with Pharmakon for up to $175m
Pharmaceutical Technology
APRIL 6, 2023
US-based biotechnology company ImmunoGen has signed a term loan financing facility worth up to $175m with the entities of Pharmakon Advisors. ImmunoGen will use the proceeds from the agreement to support its growth trajectory and bolster its balance sheet. The company will receive the loan facility in two tranches.
Sales 130
130 
Sonoma signs deal to set up manufacturing centre for cell therapies
Pharmaceutical Technology
AUGUST 25, 2022
Sonoma Biotherapeutics has signed a lease agreement for setting up an 83,000ft² research and development (R&D) and manufacturing centre for cell therapies. The post Sonoma signs deal to set up manufacturing centre for cell therapies appeared first on Pharmaceutical Technology.
Manufacturing 130
130 
Thinking of signing your company up for DrugPatentWatch?
Drug Patent Watch
NOVEMBER 10, 2020
The post Thinking of signing your company up for DrugPatentWatch? We prefer simple flat-rate unrestricted subscriptions — we’ll work on your terms, and with your favorite subscription contract template, to find a solution that fits. If your colleagues would like to…. appeared first on DrugPatentWatch - Make Better Decisions.
134 
Boost for Amazon’s telehealth business, as Hilton signs up
pharmaphorum
NOVEMBER 16, 2021
The online retail giant first started offering the telemedicine service to some of its own employees in 2019, setting it up in collaboration with Oasis Medical Group, but in March this year announced its intention to offer it to all US employees as well as other companies. million employees, but brought that to a close earlier this year.
Pharmacy 125
125 
MSD signs up Daiichi Sankyo in multibillion dollar deal to develop ADCs
Pharmaceutical Technology
OCTOBER 20, 2023
Daiichi Sankyo will receive an upfront payment of $4bn and will be eligible for additional milestone payments of up to $22bn.
Development 147
147 Development 147
147 
Open enrollment for ACA insurance has already had a record year for sign-ups
NPR Health - Shots
JANUARY 13, 2023
Nearly 16 million people have already signed up for health insurance through the Affordable Care Act. There are still three more days to sign up. Story aired on ATC on Jan. 12, 2023.)
64 
An Early Warning Sign of Dementia Risk May Be Keeping You Up at Night, Says New Study
AuroBlog - Aurous Healthcare Clinical Trials blog
SEPTEMBER 30, 2022
We spend a third of our lives asleep. And a quarter of our time asleep is spent dreaming. So, for the average person alive in 2022, with a life expectancy of around 73, that clocks in at just over six years of dreaming. Yet, given the central role that dreaming plays in our lives, we […].
Clinical Trials 183
183 
Celltrion signs up to support Rani’s oral biosimilar copy of J&J’s Stelara, lands right of first negotiation
Fierce Pharma
JANUARY 10, 2023
Celltrion signs up to support Rani’s oral biosimilar copy of J&J’s Stelara, lands right of first negotiation. Tue, 01/10/2023 - 10:24.
52 
Open enrollment for ACA insurance is about to close. It's already a record year for sign-ups
NPR Health - Shots
JANUARY 12, 2023
Nearly 16 million people have enrolled so far, and people can still sign up in most places until Sunday.
60 
Sandoz, nearing Novartis split, signs up to commercialize Samsung Bioepis' Stelara biosimiliar
Fierce Pharma
SEPTEMBER 11, 2023
After plotting a course to grow by leveraging its biosimilar expertise, Sandoz has inked a deal to get involved in one of the industry's next major biosim debuts. | The blockbuster inflammatory med's patents begin to expire this year, leaving biosimilar makers scrambling for a piece of the large market.
Marketing 97
97 Marketing 97
97 
After long wait, Editas reveals first data for CRISPR gene editing treatment
Bio Pharma Dive
SEPTEMBER 29, 2021
Early study results offer some hopeful signs of efficacy, but the small number of patients treated and short follow-up limit firmer conclusions.
Gene Editing 356
356 
Signing up for Marketplace Health Insurance During COVID-19: An Important Update
Triage Cancer
SEPTEMBER 3, 2020
Have you thought about signing up for an individual plan through the Marketplace? Under FEMA SEP, you can sign up for a Marketplace plan, if: You live in an area during a FEMA-declared disaster or emergency (right now, all US states are covered under the COVID-19 pandemic national emergency declaration).
69 
Help Experts Investigate PTSD, Nightmares, and Sleep Disturbances Among Veterans. Sign Up Today!
Trialfacts
MARCH 9, 2023
Participants will be compensated up to $519 for participating in this study. Should participants wake up from a bad dream, they will be asked to push an event-marker button on the wrist actigraph. Sign Up Today! The knowledge gained from this study may help patients get more refined care. Why Participate?
Research 52
52 
A smart move on tax day: Sign up for health insurance using your state's tax forms
NPR Health - Shots
APRIL 11, 2023
Paying taxes can be agonizing. So can shopping for health insurance. But a handful of states have made enrolling in subsidized or free coverage a little easier for people when they file their taxes (Image credit: d3sign/Getty Images)
114 
BridgeBio looks for comeback with trial results for muscular dystrophy drug
Bio Pharma Dive
MARCH 14, 2022
Positive signs for the experimental treatment could help shore up investor confidence in BridgeBio after the December study failure of a drug for a rare heart condition.
Drugs 264
264 
#news #biotech Daiichi Sankyo, AstraZeneca’s $5B Enhertu follow-up shows early signs of success in breast cancer
BioTech 365
MAY 8, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Daiichi Sankyo, AstraZeneca’s $5B Enhertu follow-up shows early signs of success in breast cancer.Daiichi Sankyo, AstraZeneca’s $5B Enhertu follow-up shows early signs of success in breast cancer … Continue reading (..)
Research 40
40 Research 40
40 
Study Links Artificial Sweetener to Stroke Risk, Says It Could Make Blood Stickier
AuroBlog - Aurous Healthcare Clinical Trials blog
MARCH 5, 2023
The suspected health harms of artificial sweeteners are piling up – and now a new study has linked one kind of sugar substitute to higher risks of heart health problems.
Scientist 222
222 
Sanofi leans on COPD as 'next major growth pillar' for its immunology star Dupixent: CEO
Fierce Pharma
APRIL 25, 2024
Even as new Sanofi drugs like Beyfortus and Altuviiio come into their own, the French pharma’s immunology powerhouse Dupixent shows no signs of slowing down. Even as new Sanofi drugs like Beyfortus and Altuviiio come into their own, the French pharma’s immunology powerhouse Dupixent shows no signs of slowing down.
Drugs 67
67 Drugs 67
67 
#news #biotech After boosting gene therapy focus, Bayer signs up to new cell therapy pact with Atara
BioTech 365
DECEMBER 7, 2020
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: After boosting gene therapy focus, Bayer signs up to new cell therapy pact with Atara.After boosting gene therapy focus, Bayer signs up to new cell therapy pact … Continue reading →
Gene Therapy 40
40 
GlucoModicum and Phillips-Medisize sign a design and development program for the rapid scale-up of its needle-free continuous glucose monitor
BioTech 365
SEPTEMBER 29, 2021
GlucoModicum and Phillips-Medisize sign a design and development program for the rapid scale-up of its needle-free continuous glucose monitor GlucoModicum and Phillips-Medisize sign a design and development program for the rapid scale-up of its needle-free continuous glucose monitor PRESS RELEASE … Continue reading →
Development 40
40 Development 40
40 
NHS staff sign up to Covid-19 sniffer dog trial
The Pharma Data
AUGUST 20, 2020
Ninety-two staff at Kettering General Hospital in Northamptonshire have signed up to help. “We will then be able to scale-up the use of dogs at ports of entry to identify travellers entering the country with the virus,” he said. Image copyright. MDD/Neil Pollock. Image caption.
Trials 52
52 
CDC: Signs point to an early start for flu season, with cases already ticking up in parts of the U.S.
STAT News
OCTOBER 17, 2022
Before the Covid-19 pandemic emerged, influenza trackers would begin reading tea leaves around this time of the year, looking for signs of whether there would be an early start to the flu season in the northern hemisphere and which of the various flu viruses might be responsible for the most cases over the coming winter.
142 
SK pharmteco to manufacture Ferring Pharmaceuticals’ gene therapy for bladder cancer
BioPharma Reporter
APRIL 22, 2024
SK pharmteco has signed an agreement with Ferring Pharmaceuticals, to scale up commercial manufacturing capacity for the drug substance of Ferringâs intravesical gene therapy Adstiladrin.
Gene Therapy 59
59 
C4XD and AstraZeneca enter $402m deal to develop respiratory disease therapy
Pharmaceutical Technology
NOVEMBER 28, 2022
C4X Discovery (C4XD) and AstraZeneca have entered an exclusive global licensing agreement worth up to $402m to develop oral therapy to treat inflammatory and respiratory ailments. The deal has been signed to develop the C4X NRF2 Activator programme for these ailments. This includes an upfront payment of $2m from AstraZeneca.
Development 264
264 
Novo Nordisk joins molecular glue club with Neomorph deal
pharmaphorum
FEBRUARY 27, 2024
Novo Nordisk has signed a wide-ranging deal with US molecular glue biotech Neomorph that could be worth up to $1.46
96 
Breaking Down Barriers: Helping Patients Get Therapies Quickly
Drug Channels
APRIL 26, 2024
To keep up with CoverMyMeds and all the action at Asembia, click here to sign up for daily recaps from Asembia. Click here to learn more about CoverMyMeds’ comprehensive technology solutions. Meet CoverMyMeds in Booth 1305 at the Asembia AXS24 Summit. Read on for Kevin’s insights.
Drugs 70
70 Drugs 70
70 
Sanofi and GSK sign agreements with the Government of Canada to supply up to 72 million doses of adjuvanted COVID-19 vaccine
BioTech 365
SEPTEMBER 22, 2020
Sanofi and GSK sign agreements with the Government of Canada to supply up to 72 million doses of adjuvanted COVID-19 vaccine Agreements relate to vaccine candidate using Sanofi’s recombinant protein-based technology and GSK’s pandemic adjuvant Both companies are committed to … Continue reading →
Vaccination 40
40 
Omicron boosters: Do I need one, and if so, when?
NPR Health - Shots
SEPTEMBER 5, 2022
The CDC is urging anyone who is eligible to sign up but some vaccine experts say some people might want to wait. Updated COVID boosters are now available for anyone age 12 or older. Image credit: Rogelio V. Solis/AP)
Vaccination 143
143 
Sanofi and Innate Pharma extend cancer therapeutics partnership
Pharmaceutical Technology
DECEMBER 19, 2022
Innate is also eligible to receive a total of up to $1.43bn (€1.35bn) in preclinical, clinical, regulatory and commercial milestone payments and royalty payments on net sales in the future. As per the deal, Sanofi will hold an option to include up to two further ANKET targets.
Development 264
264 
More people than ever buy insurance on Healthcare.gov
NPR Health - Shots
JANUARY 13, 2023
It's the last weekend for Obamacare open enrollment, and nearly 16 million Americans have signed up for a health insurance plan. Image credit: Subin Yang)
110 
Higher income economies sign up to global Covid-19 vaccine initiative, but not US, China or Russia
BioPharma Reporter
SEPTEMBER 22, 2020
A project run by Gavi, the vaccine alliance, and the World Health Organization (WHO) to guarantee fair access to COVID-19 vaccines worldwide has secured the backing of 64 higher income economies, with a further 38 economies expected to sign in the coming days.
Vaccination 98
98 
BioNTech’s RNA vaccine sparks potential in pancreatic cancer
Pharmaceutical Technology
MAY 11, 2023
Half of these patients experienced a rise in neoantigen-specific T cells which persisted for up to two years. At an 18-month follow-up, those who received the treatment were reported to have a longer recurrence-free survival, and the authors concluded that the T cell responses correlated with delayed disease recurrence.
RNA 345
345 
China signs up to WHO supported global COVID-19 vaccine program
BioPharma Reporter
OCTOBER 9, 2020
China has joined the global effort called COVAX to ensure equitable global access to COVID-19 vaccines.
Vaccination 74
74 
Cullinan Oncology signs licence deal with Harbour BioMed
Pharmaceutical Technology
FEBRUARY 14, 2023
Cullinan Oncology has signed an exclusive licence with Harbour BioMed for clinical-stage B7H4 x 4-1BB bispecific immune activator HBM7008’s (CLN-418) development and marketing in the US. The post Cullinan Oncology signs licence deal with Harbour BioMed appeared first on Pharmaceutical Technology.
Antibody 130
130 
A 'medical cost-sharing' plan left this minister to pay most of his $160,000 bill
NPR Health - Shots
JANUARY 9, 2023
Jeff King had signed up for an alternative that left members of the plan to share the costs of health care. Instead of health insurance, the Rev. That meant lower premiums, but a huge hospital bill. Image credit: Bram Sable-Smith/KHN)
105 
BMG Pharma and HTL sign a development agreement to manufacture BMG’s new biopolymer
Pharma Mirror
SEPTEMBER 19, 2021
With this agreement, HTL will exclusively develop, scale-up, and supply a high-grade functional injectable Hyaluronic Acid based active ingredient, Sodium Hyaluronate Lipoate Formate (SHLF), for a major part of BMG Pharma’s products.
Manufacturing 130
130 
Apple and Masimo face off in trial over patient monitoring patents
STAT News
APRIL 4, 2023
Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday. You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Meet the street medicine team using tech to build trust with unhoused patients Read the rest…
Life Science 105
105 
New Signify details, out-of-state telehealth use, and Fitbits to study brain exercise
STAT News
SEPTEMBER 23, 2022
Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday. You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. New details about the Signify bidding war Read the rest…
Life Science 119
119 Life Science 119
119 
Telehealth companies that provide abortion pills grapple with regulatory uncertaintyÂ
STAT News
APRIL 25, 2023
Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday. You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Telehealth providers stay nimble amid regulatory uncertainty Read the rest…
Life Science 98
98 Life Science 98
98 
Epic and Microsoft’s AI collaboration, Amazon and 3M, & Abbott’s CGM momentum
STAT News
APRIL 20, 2023
Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday. You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Researchers test Microsoft and Epic’s AI Read the rest…
Life Science 98
98 
GoodRx hires former tech exec as CEO, Amazon shutters Halo, and Teladoc beats expectations
STAT News
APRIL 27, 2023
Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday. You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. An unvarnished look at health care’s AI reality Read the rest…
Life Science 98
98 Life Science 98
98 
Let's personalize your content